Le gouvernement met en place la distribution de naloxone à Moscou. Mais est-ce suffisant ?

L’obstination de la Russie quand il s’agit de prendre en considération des approches basées sur des preuves scientifiques a abouti à un coût énorme.

Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

Drug treatment centres in Moscow have reportedly begun distributing the overdose reversal drug naloxone to people who use heroin and other opiates.

Russia’s chief narcologist, Evgeny Brun, told news website m24.ru that treatment centres in the capital began providing naloxone in July this year, following the purchase of some 30,000 doses. Brun says that the government will evaluate the naloxone initiative in spring 2017.

Naloxone is an opioid antagonist that is contained within the World Health Organisation’s (WHO) list of essential medicines. It is administered - typically through an injection into the muscle - to someone who has suffered an opioid overdose; by immediately reversing the opioid’s effects, it reduces the likelihood of a fatality.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to theIDPC Monthly Alert.

Thumbnail: Flickr CC Alexey Kljatov